Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Semi-Solid Dosage Contract Manufacturing Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The market for contract manufacturing of semi-solid dosage forms has experienced substantial expansion recently, with projections indicating continued strong growth. This sector is expected to increase from $17.97 billion in 2025 to $19.89 billion in 2026, reflecting a compound annual growth rate of 10.7%. Several factors have fueled this growth during the preceding period, including the increasing intricacy of pharmaceutical development pipelines, mounting cost pressures associated with in-house production, a broader adoption of topical and transdermal drug applications, an escalating demand for outsourced manufacturing solutions, and the emergence of specialized capabilities within contract manufacturing organizations.
The domain of contract manufacturing for semi-solid dosage forms is poised for substantial expansion in the coming years, projecting a market valuation of $29.52 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.4%. This projected growth is fueled by several key factors, including a heightened need for individually tailored topical treatments, greater investment in cutting-edge formulation techniques, an increase in the outsourcing of cosmeceutical production, a growing emphasis on eco-friendly excipients, and more stringent regulatory oversight concerning manufacturing excellence. Furthermore, several significant trends are expected to shape this period, such as a greater propensity for companies to outsource the production of semi-solid drugs, a surge in the demand for specialized dermatological preparations, the wider implementation of adaptable manufacturing processes, a proliferation of formulations derived from biological and natural sources, and an elevated commitment to production that adheres strictly to regulatory standards.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25899&type=smp
Semi-Solid Dosage Contract Manufacturing Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing incidence of dermatological conditions is poised to be a significant catalyst for the expansion of the contract manufacturing sector for semi-solid dosage forms. These conditions, which impact the skin’s aesthetic and physiological roles, frequently manifest through symptoms like redness, swelling, or aberrant dermal formations. Factors such as escalating environmental contamination are contributing to this upward trend, compromising the skin’s natural protective barriers and subsequently heightening susceptibility to sensitivities, allergic responses, and chronic skin ailments. The contract manufacturing of semi-solid formulations plays a crucial role in mitigating skin diseases by facilitating the production of superior, consistently developed topical therapies that are instrumental in preserving and enhancing dermal well-being. As an illustration, Cancer Research UK reported in February 2023 that melanoma skin cancer cases in the United Kingdom are projected to rise from approximately 20,800 annually during the 2023–2025 period to an estimated 26,500 cases by 2038–2040. Consequently, the widespread occurrence of skin disorders directly correlates with the burgeoning growth of the semi-solid dosage contract manufacturing market.
Semi-Solid Dosage Contract Manufacturing Market Segment Analysis: What Are The Major Market Categories?
The semi-solid dosage contract manufacturing market covered in this report is segmented –
1) By Type: Topical, Transdermal, Oral
2) By Material Type: Synthetic, Natural, Bio-Based
3) By Company Size: Large Size Companies, Medium And Small Size Companies
4) By Therapeutic Application: Dermatology, Pain Management, Hormonal Therapy, Wound Care, Ophthalmic Disorders, Other Therapeutic Applications
5) By End Use: Pharmaceutical Companies, Cosmeceutical Companies, Other End Uses
Subsegments:
1) By Topical: Creams, Ointments, Gels, Lotions, Pastes, Foams
2) By Transdermal: Transdermal Gels, Transdermal Creams, Transdermal Sprays, Transdermal Emulsions, Medicated Patches
3) By Oral: Oral Gels, Oral Pastes, Oral Suspensions, Oral Emulsions, Oral Jellies
Semi-Solid Dosage Contract Manufacturing Market Industry Trends: What Changes Are Reshaping Demand?
Key players within the semi-solid dosage contract manufacturing sector are channeling resources into strategic ventures to penetrate emerging markets and cultivate novel advancements. Such strategic investments constitute substantial, forward-looking financial commitments designed to bolster a firm’s fundamental objectives, its trajectory for expansion, or its standing in the competitive landscape. As an illustration, LGM Pharma, an American entity specializing in contract manufacturing of semi-solid dosage forms, declared in March 2025 its intention to invest over $6 million for the expansion of its manufacturing facility in Rosenberg, Texas. This financial injection is slated to enhance the production capabilities for a range of pharmaceutical preparations, including liquids, suspensions, semi-solids, and suppositories, thereby addressing the escalating need for domestically produced pharmaceuticals. This initiative is congruent with LGM Pharma’s continuous progress in the realm of prescription drug development, encompassing both 505(b)(2) and ANDA pathways. The enhancements at the Rosenberg location are intended to facilitate increased output while rigorously adhering to FDA mandates and contemporary good manufacturing standards, with operations continuing seamlessly throughout the expansion period.
Semi-Solid Dosage Contract Manufacturing Market Leading Companies Driving Competitive Growth
Major companies operating in the semi-solid dosage contract manufacturing market are The Lubrizol Corporation, Recipharm AB, Piramal Pharma Solutions Inc., Cambrex Corporation, ANI Pharmaceuticals, Aurigene Pharmaceutical Services Limited, DPT Laboratories Ltd., Douglas Pharmaceuticals Ltd., Mission Pharmacal Co., Bora Pharmaceuticals Co. Ltd., Ascendia Pharmaceuticals Inc., Fermion Oy, Ferndale Pharma Group, Sterling Pharmaceutical Services LLC, Aphena Pharma Solutions Inc., Eubioco LLC, Madras Pharmaceuticals, Quality CDMO, Axxelent Pharma Science, Tergus Pharma, MedPharm Ltd., Alcami Corporation
Access The Complete Semi-Solid Dosage Contract Manufacturing Market Report:
Semi-Solid Dosage Contract Manufacturing Market Global Footprint: Which Region Holds Market Leadership?
North Americawas the largest region in the semi-solid dosage contract manufacturing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the semi-solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
